Search
for
Sort by
Research 121–150 of 1000+
- Pharma in the bedroom . . . and the kitchen. . . . The pharmaceuticalisation of daily life
- Biochemical Testing of the Thyroid: TSH is the Best and, Oftentimes, Only Test Needed – A Review for Primary Care
- Corneodesmosin gene ablation induces lethal skin-barrier disruption and hair-follicle degeneration related to desmosome dysfunction
- Opposing impacts on healthspan and longevity by limiting dietary selenium in telomere dysfunctional mice
- Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
- Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial
- Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia
- Telomere dysfunction impairs epidermal stem cell specification and differentiation by disrupting BMP/pSmad/P63 signaling
- Hypothalamic DNA methylation in rats with dihydrotestosterone‐induced polycystic ovary syndrome: effects of low‐frequency electro‐acupuncture
- miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Estimation methods for human circadian phase by use of peripheral tissues
- Shock Wave Therapy for Erectile Dysfunction: Marketing and Practice Trends in Major Metropolitan Areas in the United States
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study
- Medications Most Commonly Associated With Erectile Dysfunction: Evaluation of the Food and Drug Administration National Pharmacovigilance Database
- Role of Environmental Factors and Gonadotoxin Exposure in Unexplained Male Infertility
- Does treatment with dutasteride or finasteride has impact on renal morphology? Experimental study
- Secreted Frizzled‐Related Protein 2 ( SFRP2 ) Induces Follistatin‐Like 1 ( FSTL1 ) to Regulate Dihydrotestosterone ( DHT )‐Induced Dermal Papilla Cell Mitochondrial Dysfunction and Senescence
- Myo-Inositol for Cutaneous Manifestations of Polycystic Ovary Syndrome: An International Delphi Consensus Recommendation for Dermatology Practice
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Sexual Dysfunction in Polycystic Ovary Syndrome (PCOS): A Biopsychosocial Approach to Assessment and Management
- Risk assessment of the top 60 drugs for drug-related sexual dysfunction: a disproportion analysis from the Food and Drug Administration adverse event reporting system
- Advances in the Molecular Pathogenesis and Targeted Therapy of Psoriasis
- Unravelling the link between insulin resistance and androgen excess
- Erectile dysfunction from mechanisms to medicines with a focus on the application of topical Minoxidil
- Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- Progenitor Cell Dysfunctions Underlie Some Diabetic Complications
- PCOS in Adolescence and Type 2 Diabetes